Literature DB >> 24133698

Notice to readers: final 2012 reports of nationally notifiable infectious diseases.

.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24133698      PMCID: PMC4604800     

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


× No keyword cloud information.
The tables listed in this report on pages 970–982 summarize finalized data, as of June 30, 2013, from the National Notifiable Diseases Surveillance System (NNDSS) for 2012. These data will be published in more detail in the Summary of Notifiable Diseases — United States, 2012 (1). Because no cases were reported in the United States during 2012, the following diseases do not appear in these early release tables: anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome–associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and nonneuroinvasive; yellow fever; and viral hemorrhagic fevers. Policies for reporting NNDSS data to CDC can vary by disease or reporting jurisdiction depending on case status classification (i.e., confirmed, probable, or suspected). The publication criteria used for the 2012 finalized tables are listed in the “Print Criteria” column of the NNDSS event code list, available at http://wwwn.cdc.gov/nndss/document/nndss_event_code_list_2012.pdf. In addition, only cases from reporting jurisdictions where the nationally notifiable disease is reportable are published. The NNDSS website is updated annually to include the latest national surveillance case definitions approved by the Council of State and Territorial Epidemiologists for classifying and enumerating cases of nationally notifiable infectious diseases. Population estimates are from the National Center for Health Statistics postcensal estimates of the resident population of the United States for July 1, 2011–July 1, 2012, by year, county, single-year of age (0 to ≥85 years), bridged-race, (white, black or African American, American Indian or Alaska Native, Asian or Pacific Islander), Hispanic origin (not Hispanic or Latino, Hispanic or Latino), and sex (vintage 2011), prepared under a collaborative arrangement with the U.S. Census Bureau. Population estimates for states are available at http://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#vintage2011 as of June 13, 2013. Population estimates for territories are 2012 estimates from the U.S. Census Bureau (2).
TABLE 2

Reported cases of notifiable diseases,* by geographic division and area — United States, 2012

AreaTotal Resident Population (in thousands)Arboviral diseases†

California serogroup virusesEastern equine encephalitis virusPowassan virusSt. Louis encephalitis virusWest Nile virus





Neuro-invasiveNonneuro-invasiveNeuro-invasiveNeuro-invasiveNeuro-invasiveNonneuro-invasiveNeuro-invasiveNonneuro-invasive
United States 311,589738157122,8722,801
New England 14,519——9———4221
 Connecticut3,587——————129
 Maine1,329——————1—
 Massachusetts6,607——7———258
 New Hampshire1,318——————1—
 Rhode Island1,051——————22
 Vermont627——2———12
Mid. Atlantic 41,0811——1——11699
 New Jersey8,835——————2226
 New York (Upstate)11,2321——1——3531
 New York City8,270——————2615
 Pennsylvania12,744——————3327
E.N. Central 46,504163—2——494253
 Illinois12,860——————187103
 Indiana6,51621————4631
 Michigan9,877——————14161
 Ohio11,541121————7645
 Wisconsin5,71021—2——4413
W.N. Central 20,6414——4——225437
 Iowa3,064——————1120
 Kansas2,870——————2036
 Minnesota5,3474——4——3436
 Missouri6,009——————173
 Nebraska1,842——————42151
 North Dakota685——————3950
 South Dakota824——————62141
S. Atlantic 60,5443956———185129
 Delaware908——————27
 District of Columbia619——————82
 Florida19,082——2———5221
 Georgia9,812——1———4653
 Maryland5,840——————2522
 North Carolina9,65126—2———7—
 South Carolina4,6732—————209
 Virginia8,1042—1———2010
 West Virginia1,85595————55
E.S. Central 18,54810—————173192
 Alabama4,804——————3824
 Kentucky4,367——————1310
 Mississippi2,9771—————103144
 Tennessee6,4009—————1914
W.S. Central 36,9303———121,1461,312
 Arkansas2,939——————4420
 Louisiana4,575——————155180
 Oklahoma3,784——————10388
 Texas25,6323———128441,024
Mountain 22,345——————190165
 Arizona6,467——————8746
 Colorado5,116——————6269
 Idaho1,584——————512
 Montana998——————15
 Nevada2,720——————54
 New Mexico2,079——————2423
 Utah2,814——————32
 Wyoming567——————34
Pacific 50,477——————301193
 Alaska724————————
 California37,684——————297182
 Hawaii1,378————————
 Oregon3,868———————11
 Washington6,823——————4—

Territories
 American Samoa55————————
 C.N.M.I.52————————
 Guam160————————
 Puerto Rico3,707——————1—
 U.S. Virgin Islands106————————

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Totals reported to the Division of Vector-Borne Infectious Diseases (DVBD), National Center for Emerging and Zoonotic Infectious Diseases (NCZVED) (ArboNET Surveillance), as of June 1, 2013.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Includes cases reported as wound and unspecified botulism.

Totals reported to the Division of STD Prevention, NCHHSTP, as of May 29, 2013.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Totals reported to the Division of STD Prevention, NCHHSTP, as of May 29, 2013.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Total number of reported laboratory-positive dengue cases including all confirmed cases [by anti-dengue virus (DENV) molecular diagnostic methods or seroconversion of anti-DENV IgM] and all probable cases (by a single, positive anti-DENV IgM). Totals reported to the DVBD, NCEZID (ArboNET Surveillance), as of June 1, 2013.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Totals reported to the Division of STD Prevention, NCHHSTP, as of May 29, 2013.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Total number of HIV cases reported to the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) through December 31, 2012.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Totals reported to the Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), as of December 31, 2012.

Streptococcus pneumoniae, invasive disease. The previous categories of invasive pneumococcal disease among children less than 5 years and invasive, drug-resistant Streptococcus pneumoniae were eliminated. All cases of invasive Streptococcus pneumoniae disease, regardless of age or drug resistance are reported under a single disease code.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Totals reported to the Influenza Division, NCIRD, as of December 31, 2012.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Includes E. coli O157:H7; Shiga toxin-positive, serogroup non-O157; and Shiga toxin positive, not serogrouped.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Total case count includes four unknown case status reports.

Includes the following categories: primary, secondary, latent (including early latent, late latent, and latent syphilis of unknown duration), neurosyphilis, late (including late syphilis with clinical manifestations other than neurosyphilis), and congenital syphilis. Totals reported to the Division of STD Prevention, NCHHSTP, as of May 29, 2013.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Totals reported to the Division of Tuberculosis Elimination, NCHHSTP, as of June 15, 2013.

N: Not Reportable U: Unavailable —: No reported cases C.N.M.I.: Commonwealth of the Northern Mariana Islands.

No cases of anthrax; eastern equine encephalitis virus disease, nonneuroinvasive; poliomyelitis, paralytic; poliovirus infection, nonparalytic; Powassan virus nonneuroinvasive disease; severe acute respiratory syndrome-associated coronavirus disease (SARS-CoV); smallpox; western equine encephalitis virus disease, neuroinvasive and non-neuroinvasive; yellow fever; and viral hemorrhagic fevers were reported in the United States during 2012. Data on chronic hepatitis B and hepatitis C virus infection (past or present) are not included because they are undergoing data quality review.

Totals reported to the Division of Viral Diseases, NCIRD, as of May 1, 2013.

Vibriosis refers to any species of the family Vibrionaceae, other than toxigenic Vibrio cholerae O1 or O139.

  20 in total

Review 1.  Immune persistence after pertussis vaccination.

Authors:  Zhiyun Chen; Qiushui He
Journal:  Hum Vaccin Immunother       Date:  2017-01-03       Impact factor: 3.452

2.  The impact of past vaccination coverage and immunity on pertussis resurgence.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Sci Transl Med       Date:  2018-03-28       Impact factor: 17.956

3.  A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.

Authors:  Nina Wressnigg; P Noel Barrett; Eva-Maria Pöllabauer; Maria O'Rourke; Daniel Portsmouth; Michael G Schwendinger; Brian A Crowe; Ian Livey; Thomas Dvorak; Bernhard Schmitt; Markus Zeitlinger; Herwig Kollaritsch; Meral Esen; Peter G Kremsner; Tomas Jelinek; Roland Aschoff; Roland Weisser; Ingomar F K Naudts; Gerald Aichinger
Journal:  Clin Vaccine Immunol       Date:  2014-09-03

4.  Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early Lyme disease patients.

Authors:  Alison W Rebman; Lauren A Crowder; Allison Kirkpatrick; John N Aucott
Journal:  Clin Rheumatol       Date:  2014-06-13       Impact factor: 2.980

5.  Adolescent immunization coverage and implementation of new school requirements in Michigan, 2010.

Authors:  Rachel C Potter; Stefanie F DeVita; Patricia A Vranesich; Matthew L Boulton
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

6.  Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of age.

Authors:  Gary S Marshall; Vitali Pool; David P Greenberg; David R Johnson; Xiaohua Sheng; Michael D Decker
Journal:  Clin Vaccine Immunol       Date:  2014-09-17

7.  Factors Related to Pertussis and Tetanus Vaccination Status Among Foreign-Born Adults Living in the United States.

Authors:  Liliana Sánchez-González; Alfonso Rodriguez-Lainz; Alissa O'Halloran; Ali Rowhani-Rahbar; Jennifer L Liang; Peng-Jun Lu; Peter M Houck; Stephane Verguet; Walter W Williams
Journal:  J Community Health       Date:  2017-06

8.  Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Clin Vaccine Immunol       Date:  2015-11-11

9.  Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes.

Authors:  Elyse O Kharbanda; Gabriela Vazquez-Benitez; Heather S Lipkind; Nicola P Klein; T Craig Cheetham; Allison Naleway; Saad B Omer; Simon J Hambidge; Grace M Lee; Michael L Jackson; Natalie L McCarthy; Frank DeStefano; James D Nordin
Journal:  JAMA       Date:  2014-11-12       Impact factor: 56.272

Review 10.  Neurosyphilis.

Authors:  Christina M Marra
Journal:  Curr Neurol Neurosci Rep       Date:  2004-11       Impact factor: 6.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.